Figure 1
From: Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression
Tumor characteristics in LDL-C tertiles groups. A. Tumor size increases across LDL-C tertiles groups. Line represents the median value of tumor size in each LDL-C tertile. B. Frequency of tumor characteristics in LDL-C tertiles groups. *1LDL T1-T2 (Her2-neu positive15,5%) vs LDL T3 (Her2-neu positive 27,8%): OR 5,015 (1,678-14,988) P 0,002. *2LDL T1 (Stage II-III 54,9%) vs LDL T2-T3 (Stage II-III 69,6%): OR 0,543 (0,313-0,943) P 0,029. Kruskall-Wallis test. ER: Estrogen Receptor; PR: Progesterone Receptor; LVI: Lymphovascular Invasion; LN: Lymph Nodes.